Literature DB >> 12167617

Phosphorylation-dependent interaction of the asialoglycoprotein receptor with molecular chaperones.

Tianmin Huang1, Haiteng Deng, Allan W Wolkoff, Richard J Stockert.   

Abstract

A membrane protein trafficking mutant (Trf1) of HuH-7 alters the asialoglycoprotein (ASGPR) and transferrin receptor subcellular distribution. Expression cloning of a cDNA complementing the trf1 mutation led to the discovery of a novel casein Kinase 2 catalytic subunit (CK2alpha"). To purify potential CK2alpha" phosphorylation-dependent sorting proteins from cytosol, the ASGPR cytoplasmic domain was expressed as a GST fusion protein and immobilized on glutathione-agarose. In the absence of phosphorylation, only trace amounts of cytosol protein were bound and eluted. When the fusion protein was phosphorylated, a heterocomplex of potential sorting proteins was recovered. Mass spectrometer and immunoblot analysis identified five of these proteins as gp96, HSP70, HSP90, cyclophilin-A, and FKBP18. Treatment of HuH-7 with rapamycin to disrupt the heterocomplex reduced surface ASGPR binding activity by 65 +/- 5.7%. In Trf1 cells, surface-binding activity was 48 +/- 7% of that in HuH-7 and was not further reduced by rapamycin treatment. Immunoanalysis showed significantly fewer surface receptors on rapamycin-treated HuH7 cells than on nontreated cells, with no affect on the level of surface receptors in Trf1 cells. The data presented provide evidence that phosphorylation of the ASGPR cytoplasmic domain is required for the binding of specific molecular chaperones with the potential to regulate receptor trafficking.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12167617     DOI: 10.1074/jbc.M204786200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  9 in total

1.  Proteomic analysis of endocytic vesicles: Rab1a regulates motility of early endocytic vesicles.

Authors:  Aparna Mukhopadhyay; Edward Nieves; Fa-Yun Che; Jean Wang; Lianji Jin; John W Murray; Kristie Gordon; Ruth Hogue Angeletti; Allan W Wolkoff
Journal:  J Cell Sci       Date:  2011-02-08       Impact factor: 5.285

2.  Pseudoproteoglycan (pseudoPG) probes that simulate PG macromolecular structure for screening and isolation of PG-binding proteins.

Authors:  Keiko Nakagawa; Kosuke Nakamura; Yuji Haishima; Makiko Yamagami; Kana Saito; Hiromi Sakagami; Haruko Ogawa
Journal:  Glycoconj J       Date:  2009-11       Impact factor: 2.916

3.  Quantitative proteomic analysis of mitochondria from primary neuron cultures treated with amyloid beta peptide.

Authors:  Mark A Lovell; Shuling Xiong; William R Markesbery; Bert C Lynn
Journal:  Neurochem Res       Date:  2005-01       Impact factor: 3.996

Review 4.  CD147 immunoglobulin superfamily receptor function and role in pathology.

Authors:  Kathryn T Iacono; Amy L Brown; Mark I Greene; Sandra J Saouaf
Journal:  Exp Mol Pathol       Date:  2007-09-07       Impact factor: 3.362

5.  New liver cell mutants defective in the endocytic pathway.

Authors:  Richard J Stockert; Barry Potvin; Sangeeta Nath; Allan W Wolkoff; Pamela Stanley
Journal:  Biochim Biophys Acta       Date:  2007-04-14

Review 6.  Cyclophilin A: a key player for human disease.

Authors:  P Nigro; G Pompilio; M C Capogrossi
Journal:  Cell Death Dis       Date:  2013-10-31       Impact factor: 8.469

7.  Spongionella Secondary Metabolites, Promising Modulators of Immune Response through CD147 Receptor Modulation.

Authors:  Jon Andoni Sánchez; Amparo Alfonso; Ines Rodriguez; Eva Alonso; José Manuel Cifuentes; Roberto Bermudez; Mostafa E Rateb; Marcel Jaspars; Wael E Houssen; Rainer Ebel; Jioji Tabudravu; Luís M Botana
Journal:  Front Immunol       Date:  2016-10-24       Impact factor: 7.561

Review 8.  Dealing with the family: CD147 interactions with cyclophilins.

Authors:  Vyacheslav Yurchenko; Stephanie Constant; Michael Bukrinsky
Journal:  Immunology       Date:  2006-03       Impact factor: 7.397

9.  Human liver cell trafficking mutants: characterization and whole exome sequencing.

Authors:  Fei Yuan; Erik L Snapp; Phyllis M Novikoff; Sylvia O Suadicani; David C Spray; Barry Potvin; Allan W Wolkoff; Pamela Stanley
Journal:  PLoS One       Date:  2014-01-23       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.